Partner Fund Management Accuses Theranos of Fraud

Oct 11 2016 | 11:09pm ET

By Lawrence Delevinge and Vishaka George (Reuters) - A San Francisco-based hedge fund has filed a lawsuit against Theranos, accusing the blood testing company of using fraudulent methods to attract an investment of nearly $100 million, according to an investor letter filed by the fund.

The hedge fund, Partner Fund Management LP, filed the lawsuit in the Delaware Court of Chancery on Monday afternoon, a letter to the hedge fund’s investors said.

“Through a series of lies, material misstatements, and omissions, the defendants engaged in securities fraud and other violations by fraudulently inducing PFM to invest and maintain its investment in the company,” said the letter, which was reviewed by Reuters.

PFM said in a statement to Reuters that Theranos had "repeatedly lied" about having developed proprietary technologies that worked, and concealed the truth about the commercial viability of its technology and methods.

A spokesman for Theranos said in a statement: "The suit is without merit and Theranos will fight it vigorously. The company is very appreciative of its strong investor base that understands and continues to support the company’s mission."

The company said last week it would lay off about 340 workers, or about 43 percent of its full-time employees, as it closes its clinical labs and wellness Centers, signaling a withdrawal from the consumer blood-testing business.


In Depth

PAAMCO: Will Inflation Deflate the Asset Bubble?

Jan 30 2018 | 9:49pm ET

As the U.S. shifts from monetary stimulus to fiscal stimulus, market pricing should...

Lifestyle

CFA Institute To Add Computer Science To Exam Curriculum

May 24 2017 | 9:25pm ET

Starting in 2019, financial industry executives sitting for the coveted Chartered...

Guest Contributor

Boost Hedge Fund Marketing ROI By Raising Your ROO

Feb 14 2018 | 9:57pm ET

Tasked with delivering returns on client capital, a common dilemma for many alternative...

 

FINalternatives Trending

From the current issue of